Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The screenshots show the same study page with no additions or deletions to core information. The page content appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    - Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).
    Difference
    4%
    Check dated 2025-10-05T04:57:47.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T02:49:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:34:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T14:05:57.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has added significant content related to cancer treatments, including specific drugs and therapeutic categories, while removing various terms related to neoplasms and immunological agents.
    Difference
    6%
    Check dated 2025-08-30T11:03:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.